Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,554 | -12,687 | -24,025 | -12,880 | 60,672 |
| Depreciation Amortization | 863 | 967 | 158 | 8 | 985 |
| Income taxes - deferred | N/A | -2,500 | N/A | N/A | N/A |
| Accounts receivable | 54 | -60 | -4 | 48 | 115 |
| Accounts payable and accrued liabilities | 2,037 | -966 | 803 | 851 | -123 |
| Other Working Capital | 2,022 | -1,290 | 1,268 | 2,221 | 1,791 |
| Other Operating Activity | 6,503 | -6,039 | 4,963 | 486 | -72,402 |
| Operating Cash Flow | $-20,075 | $-22,575 | $-16,837 | $-9,266 | $-8,962 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -360 | -493 | -1,570 | -30 | N/A |
| Net Acquisitions | N/A | 1,002 | N/A | N/A | N/A |
| Investing Cash Flow | $-360 | $509 | $-1,570 | $-30 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,251 |
| Debt Repayment | N/A | -4,920 | -1,364 | -64 | -86 |
| Common Stock Issued | 47,118 | 40,185 | 24,587 | 3,469 | 1,800 |
| Dividend Paid | N/A | -470 | -623 | -140 | N/A |
| Other Financing Activity | 2,004 | 7,818 | 5,736 | 5,529 | 2,509 |
| Financing Cash Flow | $49,122 | $42,613 | $28,336 | $8,795 | $7,474 |
| Exchange Rate Effect | N/A | N/A | 3 | 6 | -4 |
| Beginning Cash Position | 31,346 | 10,799 | 868 | 1,363 | 3,865 |
| End Cash Position | 60,033 | 31,346 | 10,799 | 868 | 2,373 |
| Net Cash Flow | $28,687 | $20,547 | $9,931 | $-495 | $-1,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,075 | -22,575 | -16,837 | -9,266 | -8,962 |
| Capital Expenditure | -360 | -493 | -1,570 | -30 | 0 |
| Free Cash Flow | -20,435 | -23,068 | -18,407 | -9,296 | -8,962 |